Ahlstrom explained the necessity of offering patients with cancer telehealth opportunities and what patients with cancer will lose should telehealth waivers expire.
The coronavirus disease 2019 (COVID-19) pandemic has led to major systemic changes within health care, including the advent of telehealth.
For patients with cancer, telehealth waivers have represented the removal of geographic limitations, affording patients access to specialists they may have not otherwise easily accessed. However, with some telehealth waivers expiring, even with signs pointing to another possible COVID-19 surge, providers may no longer be able to accommodate telehealth visits.
In an interview with CancerNetwork®, Jenny Ahlstrom, the founder of CrowdCare, discussed the need for telehealth waivers and what her own experience as a patient with cancer has taught her about the importance of telehealth.
This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.